A univariate Cox analysis based on PFS as clinical outcomes revealed that tumor size, lymph node-positive, clinical stage, venous invasion, nerve invasion, serum AFP, ARID1A mutation were prognostic factors for AFPGC (P < 0.05). This evidence concerns the gene AFP and neoplasm.